Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain

A.E. Shannon, K.J. Chappell, M.J. Stoermer, S.Y. Chow, W.M. Kok, D.P. Fairlie, P.R. Young*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

Dengue Virus (DENV) infection is responsible for the world's most significant insect-borne viral disease. Despite an increasing global impact, there are neither prophylactic nor therapeutic options available for the effective treatment of DENV infection. An attractive target for antiviral drugs is the virally encoded trypsin-like serine protease (NS3pro) and its associated cofactor (NS2B). The NS2B–NS3pro complex is responsible for cleaving the viral polyprotein into separate functional viral proteins, and is therefore essential for replication. Recombinant expression of an active NS2B–NS3 protease has primarily been based on constructs linking the C-terminus of the approximately 40 amino acid hydrophilic cofactor domain of NS2B to the N-terminus of NS3pro via a flexible glycine linker. The resulting complex can be expressed in high yield, is soluble and catalytically active and has been used for most in vitro screening, inhibitor, and X-ray crystallographic studies over the last 15 years. Despite extensive analysis, no inhibitor drug candidates have been identified yet. Moreover, the effect of the artificial linker introduced between the protease and its cofactor is unknown. Two alternate methods for bacterial expression of non-covalently linked, catalytically active, NS2B–NS3pro complex are described here along with a comparison of the kinetics of substrate proteolysis and binding affinities of substrate-based aldehyde inhibitors. Both expression methods produced high yields of soluble protein with improved substrate proteolysis kinetics and inhibitor binding compared to their glycine-linked equivalent. The non-covalent association between NS2B and NS3pro is predicted to be more relevant for examining inhibitors that target cofactor-protease interactions rather than the protease active site. Furthermore, these approaches offer alternative strategies for the high yield co-expression of other protein assemblies.
Original languageEnglish
Pages (from-to)124-129
Number of pages6
JournalProtein Expression and Purification
Volume119
Early online date12 Dec 2015
DOIs
Publication statusPublished - 31 Mar 2016

Funding

AS was supported by an Australian Federal government scholarship, Australian Postgraduate Award (APA). We thank the National Health and Medical Research Council of Australia for financial support in the form of grant APP1025883 (to PY and DF) and an NHMRC Senior Principal Research Fellowship APP1027369 (to DF).

Keywords

  • dengue virus
  • protease
  • NS2B–NS3
  • cofactor inhibitor

Fingerprint

Dive into the research topics of 'Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain'. Together they form a unique fingerprint.

Cite this